Skip to main content
logo
Viva Biotech Holdings (VBIZF)
OTCMKTS · Delayed Price · Currency is USD
0.1850
0.00 (0.00%)
At close: Aug 4, 2025

Pactiv Evergreen Revenue

In the year 2024, Viva Biotech Holdings had annual revenue of 1.99B CNY, down -7.84%. Viva Biotech Holdings had revenue of 1.00B in the half year ending December 31, 2024, a decrease of -20.93%.

Revenue
1.99B CNY
Revenue Growth
-7.84%
P/S Ratio
1.62
Revenue / Employee
962.99K CNY
Employees
2,063
Market Cap
440.57M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.99B-168.93M-7.84%
Dec 31, 20232.16B-224.05M-9.42%
Dec 31, 20222.38B275.55M13.10%
Dec 31, 20212.10B1.41B201.90%
Dec 31, 2020696.96M373.90M115.74%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
Northwest Biotherapeutics1.47M
American Oncology Network1.76B
Silence Therapeutics27.70M
BioStem Technologies332.45M
Revenue Rankings

Viva Biotech Holdings News

More News